Spacer usage in prosthetic joint infections does not influence infect resolution: Retrospective analysis of 120 joints with two-stage exchange. Re: Clinical outcome and microbiological findings using antibiotic-loaded spacers in two-stage revision of prosthetic joint infections. Cabo J, Euba G, Saborido A, González-Panisello M, Domínguez MA, Agullthomampersa

Journal of Infection

Volumn 67, Issue 1, 2013, Pages 82-84

  Wimmer, Matthias D ^a   Vavken, Patrick ^b,c,d   Pagenstert, Geert I ^b   Valderrabano, Victor ^c   Randau, Thomas M ^a   Wirtz, Dieter C ^a   Gravius, Sascha ^a  

^a UNIVERSITY OF BONN   (Germany)

^b University Clinics   (Switzerland)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d HARVARD CENTER FOR POPULATION AND DEVELOPMENT STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; VANCOMYCIN;

AGED; BACTERIUM CARRIER; CEMENT SPACER; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAM NEGATIVE BACTERIUM; HUMAN; IMPLANTATION; JOINT PROSTHESIS; LETTER; MAJOR CLINICAL STUDY; MALE; PROSTHESIS INFECTION; RETROSPECTIVE STUDY; TISSUE LEVEL; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; FEMALE; HIP PROSTHESIS; HUMANS; KNEE PROSTHESIS; MALE; PROSTHESIS-RELATED INFECTIONS;

EID: 84878368955     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.02.001     Document Type: Letter

References (10)

1. Cabo J., Euba G., Saborido A., González-Panisello M., Domínguez M.A., Agulló J.L., et al. Clinical outcome and microbiological findings using antibiotic-loaded spacers in two-stage revision of prosthetic joint infections. J Infect 2011 Jul, 63(1):23-31.
2. Klekamp J., Dawson J.M., Haas D.W., DeBoer D., Christie M. The use of vanco mycin and tobramycin in acrylic bone cement: biomechanical effects and elution kinetics for use in joint arthroplasty. J Arthroplasty 1999, 14:339-346.
3. Penner M.J., Masri B.A., Duncan C.P. Elution characteristics of tobramycin and vancomycin combined in acrylic bone cement. J Arthroplasty 1996, 11:939-944.
4. Masri B.A., Duncan C.P., Beauchamp C.P. Long-term elution of antibiotics from bone-cement. An in-vivo study using the prosthesis of antibiotic-loaded acrylic-cement (PROSTALAC). J Arthroplasty 1998, 13:331-338.
5. Fink B., Vogt S., Reinsch M., Büchner H. Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses. Clin Orthop Relat Res 2011, 469:3141-3147.
6. Zimmerli W., Trampuz A., Ochsner P.E. Prosthetic-joint infections. N Engl J Med 2004 Oct 14, 351(16):1645-1654.
7. Laffer R.R., Graber P., Ochsner P.E., Zimmerli W. Outcome of prosthetic knee associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect 2006 May, 12(5):433-439.
8. Osmon D.R., Berbari E.F., Berendt A.R., Lew D., Zimmerli W., Steckelberg J.M., et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the infectious diseases society of America. Clin Infect Dis 2013 Jan, 56(1):e1-e25. [Epub 2012 Dec 6]. 10.1093/cid/cis803.
9. Jiranek W.A., Hanssen A.D., Greenwald A.S. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Jt Surg Am 2006, 88:2487-2500.
10. Mabry T.M., Hanssen A.D. Articulating antibiotic spacers: a matter of personal preference. Orthopedics 2007, 30:783-785.